![The primary goal of the Paradigm Registry is to accelerate tumor profiling based on disease biology. [iStock/LilliDay]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/307-218x150.jpeg "AI Algorithm Could Reduce Breast Cancer Mammogram False Positive Rate")
Featured Article
A recent discovery by researchers at the University of Arizona Medical School – Phoenix has shown that nanoparticle delivery of frizzled-4 (FZD4) to lung endothelial cells slows lung cancer progression and metastases.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
NCCN and Flatiron Health Extend Collaboration to Improve Cancer Care Quality with Real-World Data
Flatiron Health and the National Comprehensive Cancer Network (NCCN) have renewed their collaboration to allow more cancer centers access to Flatiron’s curated data sets based on real world data.
Mayo Clinic’s Hypothesis-Driven AI Can Improve Treatment Strategies
A new class of artificial intelligence (AI) called hypothesis-driven AI, invented recently by Mayo Clinic researchers, offers an innovative way to discover the complex causes of cancer and improve treatment strategies.
Tetracycline Antibiotics Pinpoints Targets for Novel Cancer Immunotherapies
Researchers from Osaka University report that tetracycline antibiotics help the immune system find cancer cells in a way that is different from current immunotherapies.